A Single Center, Double Blind, Randomized Crossover Study Evaluating the Bioequivalence of VIAject7 Compared to VIAject25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus.

Trial Profile

A Single Center, Double Blind, Randomized Crossover Study Evaluating the Bioequivalence of VIAject7 Compared to VIAject25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 15 Mar 2012

At a glance

  • Drugs Insulin; Insulin lispro
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Biodel
  • Most Recent Events

    • 15 Mar 2012 Planned patient number 44 added as reported by EudraCT.
    • 01 Mar 2012 Results published in Diabetes, Obesity and Metabolism.
    • 15 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top